Cytokinetics stock touches 52-week low at $41.69 amid market challenges
In a turbulent market environment, Cytokinetics , Incorporated (NASDAQ:CYTK) stock has reached its 52-week low, trading at $41.69, with a sharp 14% decline just last week. According to InvestingPro ...
Cytokinetics adds pharma veteran Landry to board ahead of drug launch
SOUTH SAN FRANCISCO - Cytokinetics , Incorporated (NASDAQ:CYTK), currently valued at approximately $5 billion in market capitalization, has announced the appointment of Robert E. Landry to its Board ...
Cytokinetics Names Robert E. Landry to Board of Directors
Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential CommercializationSOUTH SAN FRANCISCO, Calif., ...
Cytokinetics appoints Robert Landry to board of directors
Cytokinetics (CYTK) announced the appointment of Robert Landry to its Board of Directors. Mr. Landry brings over three decades of financial and ...